REDHILL BIOPHARMA LTD. Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised
REDHILL BIOPHARMA LTD. (RDHL) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of $3.00 million as of 2024-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Notes
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2025-04-10
- 2024-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $3.00M.
- 2023-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $6.00M.
- 2022-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $14.00M.
- 2021-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised $20.00M.
| Period end | Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised |
|---|---|
| 2024-12-31 | $3.00M 20-F · filed 2025-04-10 |
| 2023-12-31 | $6.00M 20-F · filed 2025-04-10 |
| 2022-12-31 | $14.00M 20-F · filed 2024-04-08 |
| 2021-12-31 | $20.00M 20-F · filed 2023-04-28 |
| 2020-12-31 | $12.00M 20-F · filed 2022-03-17 |
| 2019-12-31 | $17.00M 20-F · filed 2021-03-18 |
| 2018-12-31 | $27.00M 20-F · filed 2020-03-04 |
| 2017-12-31 | $28.00M 20-F · filed 2019-02-26 |